Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agents that target telomerase reverse transcriptase (TERT) for treating cancer and sensitizing cancer cells to genotoxic therapy

Agents that target telomerase reverse transcriptase (TERT) for treating cancer and sensitizing cancer cells to genotoxic therapy

US Patent 12440476 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting SARS-CoV-2 viral-immune interaction for COVID-19 therapy2025
Bispecific antibodies and uses thereof2025
Methods for the continuous polymerization of phosphate compounds to form polypho2025
3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitor2025
Substituted chromanes, analogs thereof, and methods of use and synthesis2025
Methods and/or use of oligonucleotide conjugates for assays and flow cytometry d2025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Electronic paper display apparatus, driving method thereof and computer-readable2025
Reagent compounds, compositions, kits, and methods for amplified assays2024
Display method of electronic identification device, controller, electronic ident2024
Catalysts and methods for enantioselective conjugate addition of amines to unsat2023
Control method for electronic ink screen, display control apparatus, and electro2023